ABSTRACT Osteocalcin (OC) is a sensitive biochemical marker for evaluating bone turnover in mammals. The role of avian OC is less clear because of the need for a chicken assay. Our objectives were to develop an assay using indirect competitive ELISA for detecting chicken serum OC and use the assay to examine the effects of perches on bone remodeling in caged hens. Anti-chicken OC polyclonal antibody was produced by immunization of rabbits with a recombinant OC from Escherichia coli. Chicken OC extracted from bone was used as a coated protein, and purified chicken OC was used for calibration. The limit of detection of the developed OC ELISA was 0.13 ng/mL. The intra-and interassay CV were <7 and <12%, respectively. The sensitivity of the developed OC ELISA was compared with a commercial Rat-Mid OC ELISA in laying hens housed in conventional cages with or without perches. Serum samples were collected from 71-wk-old White Leghorn hens subjected to 4 treatments. Treatment 1 was control chickens that never had access to perches during their life cycle. Treatment 2 chickens had perches during the pullet phase (0 to 16.9 wk of age), whereas treatment 3 chickens had perches only during the egg-laying phase of the life cycle (17 to 71 wk of age). Treatment 4 chickens always had access to perches (0 to 71 wk of age). Correlation between the 2 assays was 0.62 (P < 0.0001). Levels of serum OC using the developed chicken ELISA were higher than that detected using the Rat-Mid ELISA (P < 0.0001). Results from the chicken ELISA assay showed that hens with perch access had higher concentrations of serum OC than hens without perches during egg laying (P = 0.04). Pullet access to perches did not affect serum OC levels in 71-wk-old hens (P = 0.15). In conclusion, a chicken OC ELISA has been validated that is sensitive and accurate with adequate discriminatory power for measuring bone remodeling in chickens.
INTRODUCTION
The adult skeleton is constantly undergoing remodeling or bone turnover. Osteoclasts resorb or break down bone followed by osteoblasts forming new bone. This constant turnover of bone is critical for maintenance of skeletal health by repairing fractures and rebuilding the skeletal architecture in response to physical stress. To maintain homeostasis and balance, osteoblasts and osteoclasts communicate with one another, but sometimes bone formation and resorption become uncoupled perhaps due to age, lack of activity, or disease (Meijer et al., 1998) . Osteocalcin (OC) is a major noncollagenous protein in bone that is produced by osteoblasts (Gundberg et al., 1984) . During bone formation, most of newly synthesized OC is incorporated into bone matrix and a small fraction is secreted directly into the circulation. During bone resorption, OC is released into the blood from the bone matrix (Christenson, 1997; Polak-Jonkisz and Zwolinska, 1998; Seibel, 2005) . Osteocalcin has been used as a marker of bone turnover based on its function of tightly coupling bone formation with resorption (Christenson, 1997) . Detecting the changes of serum OC concentrations have been used broadly for evaluating bone remodeling (Banfi et al., 2010; Buranasinsup et al., 2011; Suriyachand et al., 2011; Gundberg et al., 2012) and the development of metabolic bone diseases such as osteoporosis in humans (Power and Fottrell, 1991; Eastell and Hannon, 2008; Biver et al., 2012) . Recently, OC was also recognized as an endocrine hormone regulating energy metabolism Development of an enzyme-linked immunosorbent assay for detection of chicken osteocalcin and its use in evaluation of perch effects on bone remodeling in caged White Leghorns (Karsenty, 2011; Chen et al., 2012) . Specifically, OC stimulates insulin synthesis in β-cells of the pancreas and increases adiponectin production in adipocytes leading to an increase in energy production and metabolism (Lee et al., 2007; Ferron et al., 2010a) . Several methods have been used for detecting OC in humans including RIA, ELISA, and chemical luminescence immunoassay. However, unlike humans, a convenient assay for measuring chicken OC is needed for the investigation of the biological significance of OC in bone remodeling and bone damage in laying hens such as osteoporosis. Chicken OC contains 49 amino acids, which is similar to mammalian OC (Carr et al., 1981) . A RIA for quantifying chicken OC has been developed (Hauschka et al., 1983) . The assay procedure follows the basic principle of RIA measuring the levels of scintillation based on the decline of a radioactive tracer. However, the RIA requires special equipment such as a gamma counter with technical precautions for the hazards of radioactivity, which is costly and not always available in laboratories. In addition, the operators of RIA must be strictly trained for preventing radioactive contamination. Furthermore, the RIA may take 2 d to complete, especially with large sample sizes (Barlow et al., 1986; Benkirane et al., 1991 ). An easier, more convenient assay for measuring chicken OC is needed, especially for monitoring bone health of thousands of chickens at one location.
The ELISA works on the same principle as that of the RIA. In contrast to RIA, ELISA is based on a color reaction due to an enzyme tracer. The color reaction can be collected directly in the reaction tray, which makes data collection for the ELISA much easier, more rapid, and safer by avoiding the hazards of radioactivity. In human and rodent studies, it has been demonstrated that ELISA has the same sensitivity, precision, and stability as the RIA (Benkirane et al., 1991; Carlson et al., 1999; Rahmati et al., 2008) . The ELISA is a preferred method for more direct quick results, especially for epidemiological investigations of the risk of certain diseases within large populations such as monitoring osteoporosis in laying hens. Based on the functions of OC in bone remodeling, a chicken OC ELISA may be a more convenient alternative to the avian RIA in monitoring skeletal health in poultry.
Osteoporosis, a progressive decrease in mineralized structural bone, affects hen well-being because of increased skeletal fragility and susceptibility to fracture and is responsible for 20 to 35% of all mortalities among caged White Leghorn hens (McCoy et al., 1996; Anderson, 2002; Whitehead, 2004) . Structural bone mineralization gradually decreases with age in laying hens and is generalized throughout the skeleton (Whitehead and Wilson, 1992; Hughes, et al., 1993) . Lack of activity or exercise for hens housed in conventional cages increases the risk of disease (Whitehead and Fleming, 2000; Lay et al., 2011) . Providing perches to birds housed in conventional pullet and laying cages improved skeletal health (Jendral et al., 2008; Tactacan et al., 2009; Enneking et al., 2012) . Therefore, monitoring serum OC concentrations in laying hens may provide a better understanding of the role of perches and exercise on bone remodeling. We hypothesize that hens experiencing an increase in exercise or activity through perching will have higher bone turnover and remodeling, leading to an increase in circulating levels of OC. The objectives of this study were to develop a chicken OC ELISA assay and to test its function as an indicator of bone turnover by applying the developed assay to examine the effects of perches on serum OC levels in laying hens housed in conventional cages.
MATERIALS AND METHODS

Recombinant Chicken OC
The recombinant chicken OC (His-OC) was synthesized according to the published OC sequence, 147-bp chicken OC gene fragment, using primer 1 (5′-CAG-GAATTCCACTACGCCCAGGAC-3′; underlined bases cleaved by EcoR I) and primer 2 (5′-ATACTC-
GAGCCTAGACGGGGCCGTAGAAG-3′;
underlined bases cleaved by Xho I; GenBank accession no. U10578) and pET-32a(+) vector as an expression system (Novagen, Madison, WI). Briefly, DNA fragments and the pET-32a(+) vector were digested with restriction endonucleases EcoR I and Xho I and ligated with T4 DNA ligase (TaKaRa, Dalian, China) overnight at 16°C. Both pET-32a(+)-OC and pET-32a(+) were transformed into Escherichia coli Rosetta-gami (DE3) pLyS cells (TransGen Biotech, Beijing, China) and inoculated in Luria-Bertani medium supplemented with 50 μg/mL of ampicillin. Following incubation with 0.1 mM/mL isopropy-β-d-thiogalactoside (IPTG; Kakonen et al., 1996) and centrifugation, the expression of recombinant chicken OC, linked with His-tags peptide was analyzed by using a 12% SDS-PAGE gel with Coomassie blue stain and Western blot (Cheng et al., 2001 ) with a 500-fold diluted mouse anti-His antibody (TianGen, Beijing, China). Recombinant chicken OC was purified using a prepacked column with precharged Ni Sepharose according to the manufacturer's protocol (1 mL of HisTrap fast flow crude, GE Healthcare, Amersham, Sweden).
Anti-Chicken OC Antibody
Immunization. Four male New Zealand White rabbits (BW at about 2 kg) were immunized subcutaneously with 0.9 mL (1 mg/mL) of the recombinant chicken OC conjugated with complete Freund's adjuvant at a 1:1 ratio. Booster immunizations were given every 2 wk for 4 additional injections. Blood samples were collected through rabbits' carotid arteries at 10 d after the last booster immunization.
Titer of Anti-Chicken OC Antibody. The titer of the OC antiserum that gave the greatest dilution with a positive value was determined using the checkerboard method that allows for examining multiple interactions between antigen and antibody (Yeh et al., 2008) . Antichicken antibody was purified from 100 mL of OC antiserum collected from the rabbit with the highest titer (Shanghai Youke Biotechnology Co. Ltd., China). The OC purified antibody as well as unpurified antiserum were again subjected to the checkerboard method (Yeh et al., 2008) . Briefly, the recombinant OC was serially diluted (2, 1, 0.5, and 0.25 μg/mL) with 0.5 M carbonate buffer saline (0.159 g of Na 2 CO 3 , and 0.293 g of NaHCO 3 dissolved in 100 mL of double-deionized H 2 O, pH of 9.6). The ELISA microplate was coated with 100 μL/well of each diluted recombinant OC and kept at 4°C overnight. Following blocking with PBS Tween-20 (PBST) and washing, 100 μL/well of each diluted purified or unpurified OC antibody in PBST were added (1:50; 1:500; 1:5,000; 1:10,000; 1:50,000; 1:100,000; 1:1,000,000), including a blank control (PBST only). Following incubation and washing, 100 μL/well of 1:10,000 diluted horseradish peroxidase goat anti-rabbit IgG antibody (MyBioSource Inc., San Diego, CA) was added and incubated for 1 h at room temperature, followed by adding 100 μL/well of 3,3′6,5′-tetramethybenzidin (Thermo Fisher Scientific Inc., Rockford, IL) for 15 min at room temperature. The reaction was stopped by adding 100 μL/well of 0.2 M H 2 SO 4 . The microplates were read at both 450 and 630 nm wavelengths (model 680 Microplate Reader, Bio-Rad Laboratories, Hercules, CA). The titer was defined as 3 times the SD of the blank's optical density (OD). The formula was OC antibody's OD (titer) ≥ mean (Blank OD) + 3 × SD (Blank OD) (Wu et al., 2008) .
Specificity of the Anti-Chicken OC Antibody. A 200 μg of extracted protein from each of 3 chicken keel bones, 10 μg of purified chicken OC (a gift from R. Bouillon of Katholieke University, Leuven, Belgium), and a prestrained protein weight marker ranging from 2 to 71 kDa (Bio Basic Inc., Toronto, Canada) were loaded separately to a 15% SDS-PAGE. The specificity of the anti-chicken OC antibody was examined using Western blot analysis following the procedure published previously (Cheng et al., 2001 ).
Preparation of Chicken OC ELISA
Coated Antigen. Chicken OC was extracted from bone according to the method published previously (Colombo et al., 1993) . Three chickens, 6 to 7 wk of age, were killed by cervical dislocation. The femur, tibia, humerus, and keel were immediately dissected from each of the 3 chickens. The bones without marrow were placed in PBS solution with 0.1 mM phenylmethanesulfonyl fluoride (PMSF). The bones were pooled, crushed, and lyophilized. The bone chips were frozen in liquid nitrogen for 30 min and grounded. The bone powder was separated by using an 80-mesh sieve and stored at −70°C until analysis.
Bone powder (30 g) was washed and centrifuged with 300 mL of 20 mM Tris-HCl buffer (pH = 8.0) containing proteinase inhibitor cocktail (0.1 mM PMSF, 1 mM benzamidine hydrochloride hydrate, 10 mM 6-aminocaproic acid, and 5 mM N-ethylmaleimide). Following centrifugation, the sediment was collected, and the protein was extracted with 20% HCOOH containing 0.1 mM PMSF (150 mL/g of bone powder) by dialysis for 36 h at 4°C; and further condensed by using polyethylene glycol 20,000. Protein was purified according to the method published previously (Hauschka et al., 1983) . Briefly, condensed protein solution (10 mL) was run through a Sephandex G-50 column (Whatman International Ltd., Maidstone, UK) equilibrated with 50 mM Tris buffer (pH = 8.0). The column was eluted with the same solution at a flow rate of 24 mL/h monitored by UV absorption at 280 nm wavelength. The desired fragment of effluent solution was purified by ion-exchange chromatography on diethylaminoethyl-52 cellulose (Whatman International Ltd.) equilibrated previously with 50 mM Tris buffer and eluted at 24 mL/h with 500 mL of linear gradient of 0 to 0.9 M NaCl (Colombo et al., 1993 ) monitored by UV absorption at 280 nm wavelength. The purified chicken OC was used as the coated antigen for developing the chicken OC ELISA.
Indirect Competitive ELISA. The binding reaction between the concentrations of extracted chicken OC antigen (as a coated protein) and the developed rabbit anti-chicken OC antibody (as the first antibody) was optimized by the checkerboard method (Yeh et al., 2008) . Briefly, the extracted chicken OC was serially diluted at 1:4,000, 1:8,000, 1:16,000, and 1:32,000 in 0.5 M carbonate buffer saline; and the developed rabbit anti-chicken OC antibody was diluted at 1:1,000, 1:2,000, 1:4,000, 1:8,000, 1:16,000, 1:32,000, and 1:64,000 with PBST. Following the ELISA process, as described previously, the microplates were read at wavelengths of 450 and 630 nm (μ-Quant Universal Microplate Spectrophotometer, Bio-Tek Instruments Inc., Winooski, VT). The optimal combination was between an OD of 1.5 and 2.
Sensitivity and Accuracy of the Developed Chicken OC ELISA. To detect the sensitivity of the developed chicken OC ELISA, 96-well microplates were coated with the discovered optimum concentration of the extracted chicken OC (1:8,000), blocked with 10% nonfat milk in PBST, and incubated for 2 h at room temperature. A 50 μL/well of 0 ng/mL (buffer only) and 50 μL/well of each of the 10 serial diluted purified chicken OC ranging from 500 to 0.98 ng/mL (8 set replicates) were added, followed by 50 μL/well of the optimum anti-chicken OC antibody (1:5,000), and incubated for 1 h at room temperature. Following the reaction, 110,000-fold diluted horseradish peroxidase-conjugated goat-anti rabbit IgG (MyBioSource, San Diego, CA) was added, incubated for 1 h at room temperature, followed by adding 100 μL/well of 3,3′6,5′-tetramethybenzidin, and incubated for 15 min in the dark at room temperature. The color reaction was stopped by adding of 100 μL/well of 0.2 M H 2 SO 4 . Eight negative controls were also run in the same microplate using PBST solution instead of anti-OC antibody (without the 1st antibody). The OD was measured at wavelengths of 450 and 630 nm. Sensitivity was evaluated according to the inhibition rate [i.e., limit of detection (LOD) and limit of quantification (LOQ)]. Inhibition binding of 50% (IC 50 ) was also estimated, which represented the concentration of OC that produced 50% inhibition of antibody binding to coated antigen (Yeh et al., 2008; Zhang et al., 2011) . The LOD is defined as 3 SD of the blanks [i.e., the OD (LOD) = mean (0 OD) -3 × SD (0 OD) ]. The LOQ is defined as 10 SD of the blanks [i.e., the OD (LOQ) = mean (0 OD) -10 × SD (0 OD) (Wu et al., 2008; Ecker and Cichna-Markl, 2012) ]. The calibrated concentrations were optimized according to the LOD and LOQ.
To establish the accuracy of the developed chicken OC ELISA, the intra-and interassay CV and the recovery were analyzed (Yeh et al., 2008) . Based on the detected LOD and LOQ values, 7 optimized calibrated concentrations (i.e., 500, 250, 125, 31.25, 7.81, 1.95, and 0 ng/mL) were added to duplicate wells of each of 5 microplates. Intraassay CV was determined from the same microplate, and interassay CV was assessed from the 5 different microplates. A standard curve was constructed based on the series of calibrated concentrations on any 1 microplate. To assess the recovery of the ELISA, 3 concentrations of purified OC of 50, 25, and 5 ng/mL were added to chicken serum and run in triplicate along with the baseline (blank chicken serum). The recovery rate was calculated by the formula: recovery (%) = (detected concentration -baseline)/nominally added concentration × 100.
Effects of Serum Hemolysis and Dilution on Chicken OC ELISA. For estimating the effects of hemolysis, 2 tubes of blood samples were collected from each of 8 chickens at 28 wk of age. One tube was used for regular serum and another was strongly shaken to make hemolytic serum. The blood samples were kept at room temperature for 30 min and centrifuged at 1,500 × g for 15 min at room temperature. The hemolytic and nonhemolytic serum samples were analyzed in duplicate using the chicken OC ELISA on the same microplate. For estimating the effects of dilution, nonhemolytic serum samples were diluted at 1:2, 1:4, and 1:8 with PBST. The diluted and undiluted serum samples were analyzed in triplicate using the chicken OC ELISA.
Effects of Perch Access on the Levels of OC and Other Blood Biochemistry Markers
Hy-Line W36 White Leghorn female chickens were raised at the Purdue University Poultry Research Farm using standard management and vaccination practices under the guidelines approved by Purdue Animal User and Care Committee (no. 10-082). The chickens were housed in cages with and without perches from hatch to 71 wk of age. Two metal round perches, 32 mm in diameter with a smooth surface (Big Dutchman, Holland, MI), were used for each cage assigned for the perch treatment. Details on management of pullets (from hatch to 16.9 wk of age) and hens (17 to 71 wk of age) including perch placement within the cage were described by Enneking et al. (2012) and Hester et al. (2013) , respectively. At 17 wk of age, chickens were assigned to 1 of 4 treatments. Treatment 1 represented control chickens that never had access to perches during their life cycle (control-control). Treatment 2 chickens had perches during the pullet phase (0 to 16.9 wk of age, perch-control), whereas treatment 3 hens had perches only during the egg laying phase of the life cycle (17 to 71 wk of age, control-perch). Treatment 4 chickens always had access to perches (0 to 71 wk of age, perch-perch). Each laying cage had 9 hens, providing 439 cm 2 floor space, 16.9 cm of perch space, and 8.4 cm of feeder space per hen.
A blood sample (5 mL) was collected from each 71-wk-old hen (n = 10 hens/treatment) by cardiac puncture after sedation with sodium phenobarbital and before euthanization by cervical dislocation. Hens were bled near the end of the photoperiod before lights were turned off to measure basal levels of metabolites and to avoid any oviposition-related peaks in metabolites (Beuving and Vonder, 1977) . The uterus of each hen was palpated immediately before blood collection to confirm the lack of an egg in the uterus. Blood samples were centrifuged as previously described for collecting serum, which was stored at −80°C for subsequent measurements. None of the serum samples were hemolyzed.
The serum OC concentrations were analyzed using the chicken OC ELISA. To further analyze the accuracy and sensitivity of the chicken OC ELISA, the same samples were also examined at the same time using a commercial OC ELISA kit made for rats that also can be used for chickens and other species (Rat-Mid osteocalcin ELISA, Immunodiagnostic Systems Ltd., Fountain Hills, AZ). This commercial kit is based upon the competitive binding of soluble OC in serum to a monoclonal antibody raised against human OC, which recognizes the mid molecular part (amino acids 21 to 29) of the molecule (Christopoulou et al., 2006) .
The effects of the perch treatments on other biomarkers associated with bone remodeling were also analyzed including Ca, P, and alkaline phosphatase (ALP) activity using corresponding QuantiChrom kits (BioAssay Systems, Hayward, CA) with spectrophotometry (μ-Quant Universal Microplate Spectrophotometer, Bio-Tek Instruments Inc.) following the manufacturer's instructions.
Statistical Analysis
Analysis was done by using SAS 9.2 software (SAS Institute, 2008) . A paired-sample t-test was used to evaluate the effects of hemolysis and dilution of serum on OC concentrations. A paired t-test was also used to compare the estimated OC concentrations from the developed chicken OC ELISA with the commercial RatMid OC (Steel et al., 1997) . A Pearson correlation analysis was performed on the OC values detected using the developed chicken OC ELISA and the commercial Rat-Mid OC ELISA as well as between OC and ALP. The data from the perch study were subjected to an ANOVA using a 2 × 2 factorial arrangement (Steel et al., 1997 ) using the mixed model procedure of the SAS Institute (2008) with the presence or absence of the perches within the pullet or laying cages as the main factors. Data lacking homogeneity of variances were transformed to square root and reanalyzed. Because the statistical trends were similar between transformed and nontransformed data, all results were presented as nontransformed. The Tukey-Kramer test was used to partition differences among the interaction means for ALP (Oehlert, 2000) .
RESULTS
Expression of Recombinant OC Protein
Recombinant OC protein was expressed at approximately 26 kDa ( Figure 1A ). In vitro, OC concentrations in E. coli Rosetta-gami (DE3) pLyS cells increased from 1 to 3 h during IPTG stimulation, reaching a peak at 3 h with the levels remaining constant from 3 to 4 h (lanes 3 to 8 of Figure 1A ). Western blot analysis showed that the protein reacted with anti-His antibody ( Figure 1B) . These results demonstrated that chicken OC was successfully expressed by pET-32a(+) vector and E. coli Rosetta-gami (DE3) pLyS cells.
Western Blot Analysis of the Developed OC Protein Antibody
Anti-chicken OC antibody was produced by immunizing rabbits with the recombinant chicken OC. The concentration of the purified OC antibody was 1 mg/ mL, and the titer was 1:500,000. Western blot analysis of the purified chicken OC showed a single band (~6 kDa) detected by the developed anti-chicken OC antibody at a 1,000 fold dilution (lane 1 of Figure 2 ). In addition, the antibody specially recognized OC extracted from chicken keel bone with a single band of similar size as the purified chicken OC (lanes 2 to 4 of Figure 2 ).
Chicken OC ELISA
The checkerboard analyses showed that the optimum dilution of the coated OC was 1:8,000 and that the best dilution of the developed anti-chicken OC antibody was 1:10,000. For optimum conditions following dilution (i.e., 1:1 in volume, antibody: antigen), antibody was used at a double concentration, or 5,000-fold dilution, during the development of the chicken OC ELISA. The sensitivity of the assay was determined by IC 50 , the LOD, and the LOQ. According to the data collected from the 10 serial diluted purified OC concentrations, the IC 50 was 3.91 ng/mL; the LOD was 0.13 ng/mL; and the LOQ was 2.17 ng/mL (Table 1) .
According to the LOD and LOQ, the optimized standard curve was developed using OC serially diluted at concentrations of 500, 250, 125, 31.25, 7.81 , and 1.95 ng/mL. The intraassay CV ranged from 0 to 6.68% (Table 2) . A typical 4 parametric logistic curve fitted well with the standard curve (R 2 > 0.99, Figure 3) . The interassay CV ranged from 2.7 to 11.7%. The recoveries of OC in chicken serum ranged from 87 to 101% (Table  3) .
Chicken serum OC concentrations using the chicken OC ELISA were higher than those using Rat-Mid OC ELISA (Table 5 ) with a respective overall mean of 20.7 ± 1.7 ng/mL vs. 4.1 ± 0.6 ng/mL (P < 0.0001, overall means were not presented in tables and figures). In addition, there were 3 samples in which OC was undetectable using the rat OC ELISA. Nevertheless, there was a positive correlation between the detected serum OC concentrations measured by the chicken OC ELISA and the commercial rat OC ELISA (r = 0.62, P < 0.0001, Figure 4) .
The OC concentrations were affected by hemolysis of serum with a mean OC of 39 ± 9 ng/mL for hemolyzed vs. 50 ± 10 ng/mL for nonhemolyzed serum (P = 0.05). In addition, more than a 2-fold dilution of serum samples dramatically reduced the OC detection concentrations. Specifically, when serum samples were diluted 1:2 (50%), detectable OC concentrations were 41.5 to 50.1% of the undiluted original levels. With further serum dilutions of 1:4 (25%) and 1:8 (12.5%), the observed OC concentrations were 10 to 11.5% and 1.6 to 4.3%, respectively, of the undiluted original concentrations (Table 4) .
Perch Access on the Levels of OC and Other Blood Biochemistry Markers
Perch access during the pullet phase had no effect on serum concentrations of OC, Ca, P, and ALP activity of 71-wk-old hens (Table 5 ). The same trend occurred during the laying phase with the exception of OC. The 71-wk-old hens with access to perches in laying cages had higher serum concentrations of chicken OC than hens without perches when using the developed OC ELISA (P = 0.04) but not the Rat-Mid OC ELISA (P = 0.15). For the pullet × laying phase interaction for ALP activity (P = 0.02, Table 5), the Tukey-Kramer test was unable to partition interaction means at a P < 0.05. The ALP activity in the serum of 71-wk-old hens was lower for hens that had access to a perch only dur- 1 Values within a column represent the means ± SD averaged over 8 replicates.
2 Binding affinity (B/B 0 ) = optical density of each ostecalcin calibration/optical density of 0 ng/mL × 100.
3 Negative controls used PBS with Tween 20 instead of anti-osteocalcin antibody.
4 IC 50 : inhibition of binding at 50%. ing the pullet phase compared with the other 3 treatment groups.
DISCUSSION
Osteocalcin is a noncollagenous protein of bone matrix with a molecular size of 5.6 kDa, which is too small (a semi-antigen) to produce immunogenicity (Power et al., 1989) . Osteoclacin can be conjugated with BSA or d-galactosidase to induce an immune response (Gundberg et al., 1984; Tanaka et al., 1986) . In the present study, recombinant chicken OC was used as an antigen for developing anti-chicken OC antibody. There were 2 major reasons for using recombinant protein in this study. First, compared with OC extracted from bone, the recombinant OC has a bigger molecular size. It is about 26 kDa, which includes the 20 kDa from the Tags peptide (Tsunoda et al., 2005) and OC at 5.6 kDa (Carr et al., 1981) . The OC-tags complex has a sufficient size to induce immunogenicity. Previous studies have reported that OC is similar in its sequence across multiple species including chickens (Carr et al., 1981; Gundberg et al., 1984) . Second, recombinant protein is easier to purify and of higher quality compared with OC extracted from bone, whose molecular structure could be damaged during extraction. The quality of an antigen plays a critical role in producing an antibody with high specificity and sensitivity. The intra-(<7%) and interassay CV (<12%) of the chicken OC ELISA and the recovery rate of OC in chicken serum (87 to 101%) indicated that the developed ELISA had a high accuracy. The LOD (0.13 ng/mL), LOQ (2.17 ng/mL), and IC 50 (3.90 ng/mL) were evidence that the assay had a great sensitivity (Wu et al., 2008; Yeh et al., 2008; Zhang et al., 2011; Ecker and Cichna-Markl, 2012) . Osteocalcin easily breaks down in plasma or serum. It is possible that monoclonal antibody based on a single antigenic determinant or fragment does not recognize whole OC (Power and Fottrell, 1991) . A polyclonal antibody is a great alternative for detecting OC in plasma or serum. So far, commercial chicken OC ELISA kits are not available, but the sequence of chicken OC is similar to that of other species (Carr et al., 1981; Frazão et al., 2005) with about 70% similarity with humans (Poser et al., 1980) . Rat-Mid OC ELISA was developed based on the mid-molecular fragment of OC (amino acids 21 to 29, Immunodiagnostic Systems Ltd., Fountain Hills, AZ), which has a high degree of interspecies conservatism (Christopoulou et al., 2006) . It is produced for detecting OC in rodents but cross-reacts with OC from other species such as rabbits, chickens, and pigs. Only 2 amino acids residues are different within the OC fragment between rats and chickens (Carr et al., 1981; Lian et al., 1989; Frazão et al., 2005) . Unexpectedly, the concentrations of OC measured using Rat-Mid OC ELISA in the current study were low or even absent when compared with the levels measured using the developed chicken OC ELISA. It might be due to the detection limit (50 ng/mL) of Rat-Mid OC ELISA, which may not have given enough sensitivity for quantification of chicken serum OC from 71-wk-old hens. Previous studies have shown that OC concentrations in rats were much greater than those found in chickens (Ferron et al., 2010b; Funaoka et al., 2010) . Another possibility is that the molecular structure of chicken OC for the amino acid sequence between 21 and 29, where it differs by 2 amino acids, affected results (Christopoulou et al., 2006) . Fleming et al. (2003) reported similar findings that plasma OC concentrations of laying hens were low, even undetectable in some hens by OC RIA. In this study, OC was detected in all samples collected from 71-wk-old hens by the chicken OC ELISA with higher values than those detected by using Rat-Mid OC ELISA. Even though there was a positive correlation between the OC levels detected using the 2 assays, our results indicate that the polyclonal antibody developed for the chicken OC ELISA was a better option.
The higher serum OC in 71-wk-old laying hens as result of perch access in laying cages suggested that perching activity stimulated osteoblast activity inducing greater bone turnover. In a concurrent study, the bone mineral densities of the wing bones, femur, and keel of 71-wk-old hens with access to perches were increased compared with hens in laying cages without perches (P. Y. Hester, unpublished data). Human clinical research reported similar results in that exercise increased OC concentration and improved bone metabolism (Karlsson et al., 2003; Coiro et al., 2012) . The bone mineral content, but not bone mineral density, of the humerus and keel was higher in 12-wk-old pullets with perches compared with pullets with no access to perches (Enneking et al., 2012 ). In the current study, pullet access to perches from 0 to 16.9 wk of age showed no effect on serum OC in 71-wk-old hens, which is perhaps due to the late sampling age. Collection of blood immediately before transfer to laying cages may have resulted in a different OC response. Serum total ALP activity is another biomarker of bone formation in birds (Lumeij and Westerhof, 1987; Calabuig et al., 2010) . Sources of alkaline phosphatase include the plasma membranes of cells in bone, liver, and intestines, all of which contribute to blood levels of ALP in mammals (Watts, 1999) ; however, in chickens, levels of liver ALP are low (Bogin and Israeli, 1976; Lumeij and Westerhof, 1987) . In birds, total ALP activity in blood circulation is parallel with osteoblastic activity (Lumeij and Westerhof, 1987; Calabuig et al., 2010) . A high level of ALP activity is related to high bone turnover and bone damage such as osteoporosis of laying hens (Bell, 1971) . In this study, it is unknown why chickens that had access to perches as pullets but did not have perches in laying cages had lower ALP activity, which is indicative of lower bone formation. It was expected that if any treatment group had lower ALP activity, it would have been the control hens that never had access to a perch at any stage in their life cycle, and they had the highest levels. The serum ALP activity did not correlate with the serum OC concentrations for hens of the current study (r = −0.02; P = 0.90). Similar to the current findings, Deftos et al. (1991) and Diego et al. (1995) reported that OC concentrations and ALP activity levels did not correlate with each other in human skeletal disease. The reasons for the lack of a correlation between ALP activity and OC concentration could be that they are involved in different stages of osteoblast activity. Osteoblast differentiation is characterized by 3 stages: cell proliferation, matrix maturation, and matrix mineralization (Lian and Stein, 1992) . Alkaline phosphatase is expressed at matrix maturation, whereas OC is produced at the beginning of matrix mineralization (Siggelkow et al., 1999) . As the findings from human clinical studies indicate, the differences in changing patterns between the 2 biochemical markers suggest that they are involved in regulating bone remodeling differently (Deftos, 1991; Deftos et al., 1991; Diego et al., 1995) .
In conclusion, we developed an ELISA for detecting serum OC concentrations in chickens using a special polyclonal antibody. The assay has excellent sensitivity and accuracy. Using the developed chicken ELISA to examine the effect of perching activity on OC concentrations in laying hens, we showed that caged hens with access to perches during egg laying had higher concentrations of OC as compared with hens with no perch access. Because OC is a biomarker for bone formation and turnover, these results suggest that perching activity may induce more active bone remodeling.
